| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.67B | +19.7% |
| Gross profit | ¥0.13B | — |
| Operating income | ¥0.01B | — |
| Net income | ¥0.02B | — |
| Gross margin | 19.0% | Net margin 2.4% |
| Revenue Q/Q | +8.1% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.55B | 81.0% |
| R&D | ¥0.05B | 6.8% |
| SG&A | ¥0.07B | 10.0% |
| Tax & other | ¥-0.00B | -0.3% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
卫宁健康 ・ 仟源医药 ・ 常山药业 ・ 星星科技 ・ 开山股份 ・ 精锻科技 ・ 新天科技 ・ 新莱应材 ・ 雅本化学 ・ 隆华科技 ・ 佳创视讯 ・ 通光线缆
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies